Literature DB >> 19364797

Thiazolidinedione use and the risk of fractures.

Tjark Reblin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19364797      PMCID： PMC2665963          DOI： 10.1503/cmaj.1090005

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Thiazolidinediones: do harms outweigh benefits?

Authors:  Lorraine L Lipscombe
Journal:  CMAJ       Date:  2008-12-10       Impact factor: 8.262

2.  Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

Authors:  Steven E Kahn; Steven M Haffner; Mark A Heise; William H Herman; Rury R Holman; Nigel P Jones; Barbara G Kravitz; John M Lachin; M Colleen O'Neill; Bernard Zinman; Giancarlo Viberti
Journal:  N Engl J Med       Date:  2006-12-04       Impact factor: 91.245

3.  Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.

Authors:  Yoon K Loke; Sonal Singh; Curt D Furberg
Journal:  CMAJ       Date:  2008-12-10       Impact factor: 8.262
  3 in total
  1 in total

1.  Jiaotai Pill enhances insulin signaling through phosphatidylinositol 3-kinase pathway in skeletal muscle of diabetic rats.

Authors:  Hui Dong; Jian-hong Wang; Fu-er Lu; Li-jun Xu; Yan-lin Gong; Xin Zou
Journal:  Chin J Integr Med       Date:  2013-08-24       Impact factor: 1.978
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.